Patent · US Active

Intersession monitoring for blood fluid removal therapy

US9561316B2 · kind B2 · utility

8Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2012
Grant dateFeb 7, 2017
Priority date
Expiry dateSep 14, 2034

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01D2321/12
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patent parameters. By comparing the patient's current parameters to past parameters in response to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.